{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:40:23Z","timestamp":1781955623866,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["209407\/Z\/17\/Z"],"award-info":[{"award-number":["209407\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/12\/54\/29734"],"award-info":[{"award-number":["PG\/12\/54\/29734"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/1\/32532"],"award-info":[{"award-number":["PG\/17\/1\/32532"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/SBSRF\/20\/31005"],"award-info":[{"award-number":["FS\/SBSRF\/20\/31005"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/58\/33134"],"award-info":[{"award-number":["PG\/17\/58\/33134"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heterozygous mutations in <jats:italic>BMPR2<\/jats:italic> (bone morphogenetic protein (BMP) receptor type II) cause pulmonary arterial hypertension. BMPRII is a receptor for over 15 BMP ligands, but why <jats:italic>BMPR2<\/jats:italic> mutations cause lung-specific pathology is unknown. To elucidate the molecular basis of BMP:BMPRII interactions, we report crystal structures of binary and ternary BMPRII receptor complexes with BMP10, which contain an ensemble of seven different BMP10:BMPRII 1:1 complexes. BMPRII binds BMP10 at the knuckle epitope, with the A-loop and \u03b24 strand making BMPRII-specific interactions. The BMPRII binding surface on BMP10 is dynamic, and the affinity is weaker in the ternary complex than in the binary complex. Hydrophobic core and A-loop interactions are important in BMPRII-mediated signalling. Our data reveal how BMPRII is a low affinity receptor, implying that forming a signalling complex requires high concentrations of BMPRII, hence mutations will impact on tissues with highest <jats:italic>BMPR2<\/jats:italic> expression such as the lung vasculature.<\/jats:p>","DOI":"10.1038\/s41467-022-30111-2","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T10:02:54Z","timestamp":1651572174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1568-4842","authenticated-orcid":false,"given":"Jingxu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midory","family":"Thorikay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-7586","authenticated-orcid":false,"given":"Minmin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-5341","authenticated-orcid":false,"given":"Richard M.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-0047","authenticated-orcid":false,"given":"Randy J.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-9792","authenticated-orcid":false,"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-3120","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"30111_CR1","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1074\/jbc.M115.713487","volume":"291","author":"S Aykul","year":"2016","unstructured":"Aykul, S. & Martinez-Hackert, E. Transforming Growth Factor-\u03b2 Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding. J. Biol. Chem. 291, 10792\u201310804 (2016).","journal-title":"J. Biol. Chem."},{"key":"30111_CR2","doi-asserted-by":"publisher","first-page":"27313","DOI":"10.1074\/jbc.M112.377960","volume":"287","author":"SA Townson","year":"2012","unstructured":"Townson, S. A. et al. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex. J. Biol. Chem. 287, 27313\u201327325 (2012).","journal-title":"J. Biol. Chem."},{"key":"30111_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cytogfr.2020.09.003","volume":"57","author":"E Martinez-Hackert","year":"2021","unstructured":"Martinez-Hackert, E., Sundan, A. & Holien, T. Receptor binding competition: A paradigm for regulating TGF-\u03b2 family action. Cytokine Growth Factor Rev. 57, 39\u201354 (2021).","journal-title":"Cytokine Growth Factor Rev."},{"key":"30111_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"PPHC International","year":"2000","unstructured":"International, P. P. H. C. et al. Heterozygous germline mutations in BMPR2, encoding a TGF-\u03b2 receptor, cause familial primary pulmonary hypertension. Nat. Genet. 26, 81\u201384 (2000).","journal-title":"Nat. Genet."},{"key":"30111_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jmg.37.10.741","volume":"37","author":"JR Thomson","year":"2000","unstructured":"Thomson, J. R. et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-\u03b2 family. J. Med. Genet. 37, 741\u2013745 (2000).","journal-title":"J. Med. Genet."},{"key":"30111_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/humu.22904","volume":"36","author":"RD Machado","year":"2015","unstructured":"Machado, R. D. et al. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. Hum. Mutat. 36, 1113\u20131127 (2015).","journal-title":"Hum. Mutat."},{"key":"30111_CR7","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1093\/hmg\/ddn214","volume":"17","author":"A Sobolewski","year":"2008","unstructured":"Sobolewski, A. et al. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Hum. Mol. Genet. 17, 3180\u20133190 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"30111_CR8","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/hmg\/11.13.1517","volume":"11","author":"N Rudarakanchana","year":"2002","unstructured":"Rudarakanchana, N. et al. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum. Mol. Genet. 11, 1517\u20131525 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"30111_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson, D. W. et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13, 189\u2013195 (1996).","journal-title":"Nat. Genet."},{"key":"30111_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister, K. A. et al. Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345\u2013351 (1994).","journal-title":"Nat. Genet."},{"key":"30111_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03672-4","volume":"9","author":"S Graf","year":"2018","unstructured":"Graf, S. et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat. Commun. 9, 1416 (2018).","journal-title":"Nat. Commun."},{"key":"30111_CR12","doi-asserted-by":"publisher","unstructured":"Li, W. et al. Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice. Am. J. Respir. Crit. Care Med. 203, 1419\u20131430 https:\/\/doi.org\/10.1164\/rccm.202005-1761OC (2020).","DOI":"10.1164\/rccm.202005-1761OC"},{"key":"30111_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15425-3","volume":"11","author":"RM Salmon","year":"2020","unstructured":"Salmon, R. M. et al. Molecular basis of ALK1-mediated signalling by BMP9\/BMP10 and their prodomain-bound forms. Nat. Commun. 11, 1621 (2020).","journal-title":"Nat. Commun."},{"key":"30111_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jmb.2008.02.031","volume":"378","author":"H Yin","year":"2008","unstructured":"Yin, H., Yeh, L. C., Hinck, A. P. & Lee, J. C. Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain. J. Mol. Biol. 378, 191\u2013203 (2008).","journal-title":"J. Mol. Biol."},{"key":"30111_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1097-2765(03)00094-7","volume":"11","author":"J Greenwald","year":"2003","unstructured":"Greenwald, J. et al. The BMP7\/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605\u2013617 (2003).","journal-title":"Mol. Cell"},{"key":"30111_CR16","doi-asserted-by":"publisher","first-page":"e2104809118","DOI":"10.1073\/pnas.2104809118","volume":"118","author":"KN Hart","year":"2003","unstructured":"Hart, K. N. et al. Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-\u03b2 family. Proc. Natl. Acad. Sci. USA 118, e2104809118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"30111_CR17","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1073\/pnas.0602558103","volume":"103","author":"GP Allendorph","year":"2006","unstructured":"Allendorph, G. P., Vale, W. W. & Choe, S. Structure of the ternary signaling complex of a TGF-\u03b2 superfamily member. Proc. Natl. Acad. Sci. USA 103, 7643\u20137648 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"30111_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-7-6","volume":"7","author":"D Weber","year":"2007","unstructured":"Weber, D. et al. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct. Biol. 7, 6 (2007).","journal-title":"BMC Struct. Biol."},{"key":"30111_CR19","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/emboj\/cdg156","volume":"22","author":"TB Thompson","year":"2003","unstructured":"Thompson, T. B., Woodruff, T. K. & Jardetzky, T. S. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-\u03b2 ligand:receptor interactions. EMBO J. 22, 1555\u20131566 (2003).","journal-title":"EMBO J."},{"key":"30111_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molcel.2004.07.011","volume":"15","author":"J Greenwald","year":"2004","unstructured":"Greenwald, J. et al. A flexible activin explains the membrane-dependent cooperative assembly of TGF-\u03b2 family receptors. Mol. Cell 15, 485\u2013489 (2004).","journal-title":"Mol. Cell"},{"key":"30111_CR21","doi-asserted-by":"publisher","first-page":"15505","DOI":"10.1073\/pnas.1906253116","volume":"116","author":"EJ Goebel","year":"2019","unstructured":"Goebel, E. J. et al. Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity. Proc. Natl Acad. Sci. U. S. A. 116, 15505\u201315513 (2019).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"30111_CR22","doi-asserted-by":"publisher","first-page":"103590","DOI":"10.1016\/j.isci.2021.103590","volume":"25","author":"EJ Goebel","year":"2022","unstructured":"Goebel, E. J. et al. Structures of activin ligand traps using natural sets of type I and type II TGFbeta receptors. iScience 25, 103590 (2022).","journal-title":"iScience"},{"key":"30111_CR23","doi-asserted-by":"publisher","first-page":"14806","DOI":"10.1074\/jbc.M109.079921","volume":"285","author":"S Radaev","year":"2010","unstructured":"Radaev, S. et al. Ternary complex of transforming growth factor-\u03b21 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily. J. Biol. Chem. 285, 14806\u201314814 (2010).","journal-title":"J. Biol. Chem."},{"key":"30111_CR24","first-page":"203","volume":"9","author":"PJ Hart","year":"2002","unstructured":"Hart, P. J. et al. Crystal structure of the human T\u03b2R2 ectodomain\u2014TGF-\u03b23 complex. Nat. Struct. Biol. 9, 203\u2013208 (2002).","journal-title":"Nat. Struct. Biol."},{"key":"30111_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.molcel.2007.11.039","volume":"29","author":"J Groppe","year":"2008","unstructured":"Groppe, J. et al. Cooperative assembly of TGF-\u03b2 superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 29, 157\u2013168 (2008).","journal-title":"Mol. Cell"},{"key":"30111_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbrc.2006.10.109","volume":"351","author":"PD Mace","year":"2006","unstructured":"Mace, P. D., Cutfield, J. F. & Cutfield, S. M. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding. Biochem. Biophys. Res. Commun. 351, 831\u2013838 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"30111_CR27","doi-asserted-by":"publisher","first-page":"25111","DOI":"10.1074\/jbc.M503328200","volume":"280","author":"MA Brown","year":"2005","unstructured":"Brown, M. A. et al. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J. Biol. Chem. 280, 25111\u201325118 (2005).","journal-title":"J. Biol. Chem."},{"key":"30111_CR28","doi-asserted-by":"publisher","first-page":"31150","DOI":"10.1074\/jbc.M114.579771","volume":"289","author":"Z Wei","year":"2014","unstructured":"Wei, Z., Salmon, R. M., Upton, P. D., Morrell, N. W. & Li, W. Regulation of Bone Morphogenetic Protein 9 (BMP9) by Redox-dependent Proteolysis. J. Biol. Chem. 289, 31150\u201331159 (2014).","journal-title":"J. Biol. Chem."},{"key":"30111_CR29","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.celrep.2017.05.011","volume":"19","author":"T Saito","year":"2017","unstructured":"Saito, T. et al. Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1. Cell Rep. 19, 1917\u20131928 (2017).","journal-title":"Cell Rep."},{"key":"30111_CR30","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.1501303112","volume":"112","author":"LZ Mi","year":"2015","unstructured":"Mi, L. Z. et al. Structure of bone morphogenetic protein 9 procomplex. Proc. Natl Acad. Sci. USA 112, 3710\u20133715 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30111_CR31","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1074\/jbc.M115.683292","volume":"291","author":"H Jiang","year":"2016","unstructured":"Jiang, H. et al. The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells. J. Biol. Chem. 291, 2954\u20132966 (2016).","journal-title":"J. Biol. Chem."},{"key":"30111_CR32","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"C UniProt","year":"2021","unstructured":"UniProt, C. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480\u2013D489 (2021).","journal-title":"Nucleic Acids Res."},{"key":"30111_CR33","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1177\/1535370219880894","volume":"244","author":"EJ Goebel","year":"2019","unstructured":"Goebel, E. J., Hart, K. N., McCoy, J. C. & Thompson, T. B. Structural biology of the TGFbeta family. Exp. Biol. Med. (Maywood) 244, 1530\u20131546 (2019).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"30111_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1110\/ps.072914007","volume":"16","author":"L Goldschmidt","year":"2007","unstructured":"Goldschmidt, L., Cooper, D. R., Derewenda, Z. S. & Eisenberg, D. Toward rational protein crystallization: A Web server for the design of crystallizable protein variants. Protein Sci. 16, 1569\u20131576 (2007).","journal-title":"Protein Sci."},{"key":"30111_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S2059798317017235","volume":"74","author":"G Winter","year":"2018","unstructured":"Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr D. Struct. Biol. 74, 85\u201397 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"30111_CR36","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D. Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"30111_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D. Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D. Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30111_CR43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"30111_CR44","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1074\/jbc.M111023200","volume":"277","author":"O Korchynskyi","year":"2002","unstructured":"Korchynskyi, O. & ten Dijke, P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883\u20134891 (2002).","journal-title":"J. Biol. Chem."},{"key":"30111_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0014-5793(98)00954-5","volume":"434","author":"U Persson","year":"1998","unstructured":"Persson, U. et al. The L45 loop in type I receptors for TGF-\u03b2 family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 434, 83\u201387 (1998).","journal-title":"FEBS Lett."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30111-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:01:46Z","timestamp":1669309306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30111-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30111"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30111-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.L. is a founder and scientific advisor to Morphogen-IX. N.W.M. is a founder and CEO of Morphogen-IX. Other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2395"}}